Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

FEMA awards NYU Langone Medical Center $1.13 billion for Hurricane Sandy recovery

According to the office of U.S. Senator Charles E. Shumer (D-NY), the $1.13 billion in Federal Emergency Management Agency (FEMA) Public Assistance funding for Sandy repair work and mitigation projects at New York University’s (NYU) Langone Medical Center is the second-largest Project Worksheet in FEMA’s history.

Oct. 1, 2015 date nailed down for ICD-10

The Department of Health and Human Services (HHS) finally issued a rule finalizing Oct. 1, 2015, as the new compliance date for healthcare providers, health plans and healthcare clearinghouses to transition to ICD-10. This marks the second one-year delay for the ICD-10 transition.

Thumbnail

UCSF Medical Center and John Muir Health to form joint care network

UCSF Medical Center and John Muir Health have signed a letter of intent to develop a new company that will be equally owned and operated by both organizations. This new company, the healthcare systems say, will allow them to each remain independent yet at the same time work together on a health care network covering the whole San Francisco Bay Area region.

Thumbnail

Sunshine act payments verification process may be even more cumbersome than you think

The American Medical Association (AMA) is doing a full court press to get every member to verify his or her industry payments well before the August 27 deadline to dispute reported data because the process is turning out to be longer and more glitch prone than many anticipated.

Thumbnail

Community Health Systems Q2 results miss guidance by $90 million

Community Health Systems had a slow first quarter with winter weather disruptions that plagued its initial months of operation following its blockbuster merger with Health Management Associates. The second quarter did not do enough to lift revenue and the leading U.S. hospital operator came in short of guidance by $90 million just after other companies like LifePoint Hospitals and HCA Holdings had released stellar Q2 results for their hospitals.

Thumbnail

Senate confirms McDonald as VA secretary

The U.S. Senate voted 97 to 0 Tuesday to confirm the appointment of former Procter & Gamble CEO Robert McDonald, 61, as the new Department of Veterans Affairs secretary, a move that will bring a much needed branding expert into the VA noted David A. Shore, Ph.D., a former associate dean of the Harvard School of Public Health and an expert in leading change initiatives in healthcare organizations.

Thumbnail

Mercy faces backlash over physician pay standardization

Some physicians in the St. Louis, Missouri area are opting out of their employment contracts with the non-profit Catholic healthcare system Mercy over new efforts to standardize physician pay by linking them more directly to individual physician RVUs.

Thumbnail

HCA second quarter results show positive impact of healthcare reform

Fewer uninsured and charity-care patients, more admissions and emergency room visits, and a higher acuity and longer stays for admitted patients — these are just a few of the effects of healthcare reform that are lifting revenue for HCA Holdings, the nation’s largest publically traded hospital operator say company officials.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.